Inventor · disambiguated record
Franck Barrat
Also filed as: BARRAT FRANCK · BARRAT FRANCK J
12 granted patents·9 pending applications·80 citations·filing 2001–2023
90Inventor score
Files withDYNAVAX TECH CORP7BARRAT FRANCK5NEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL S2SCHERING CORP2INST NAT SANTE RECH MED1
Top patents by PatentIndex Score
21 records- 0191US9868955B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 16, 2018·11 cites·20 claims
- 0290US8940310B2Methods of treatment using TLR7 and/or TLR9 inhibitorsBARRAT FRANCK·Filed 2011·Granted Jan 27, 2015·17 cites·33 claims
- 0388US8759305B2Methods and compositions for inhibition of innate immune responses and autoimmunityBARRAT FRANCK·Filed 2005·Granted Jun 24, 2014·12 cites·32 claims
- 0487US9228184B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 5, 2016·10 cites·28 claims
- 0584US11197890B2Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokinesNEW YORK SOC RUPTURED & CRIPPLED MAINTAINING HOSPITAL FOR SPECIAL SURGERY·Filed 2017·Granted Dec 14, 2021·2 cites·10 claims
- 0683US8962579B2Methods and compositions for inhibition of immune responses and autoimmunityBARRAT FRANCK·Filed 2010·Granted Feb 24, 2015·6 cites·36 claims
- 0783US6670146B2Regulatory T cells; methodsSCHERING CORP·Filed 2001·Granted Dec 30, 2003·17 cites·13 claims
- 0871US9347064B2Methods of treatment using TLR7 and/or TLR9 inhibitorsDYNAVAX TECH CORP·Filed 2014·Granted May 24, 2016·1 cites·19 claims
- 0970US7122340B2Regulatory T cells; methodsSCHERING CORP·Filed 2003·Granted Oct 17, 2006·3 cites·9 claims
- 1066US9063123B2Transgenic mice expressing human toll-like receptor 8BARRAT FRANCK·Filed 2012·Granted Jun 23, 2015·1 cites·11 claims
- 1165US12427183B2Methods of treating cancer, infectious disease, and autoimmune disease using chemokinesNEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGER·Filed 2021·Granted Sep 30, 2025·0 cites·14 claims
- 1262US2025188542A1Enrichment and characterization of rare circulating cells, including progenitor cells, from peripheral blood, and uses thereofUNIV CORNELL·Filed 2023·Application pending·0 cites
- 1359US2025009779A1Methods for treating viral diseasesNEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL S·Filed 2022·Application pending·0 cites
- 1458US2024307423A1Fractions of, and molecules released in, protein rich plasma which inhibit immune responses and reduce inflammation, and methods of obtainingNEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL S·Filed 2022·Application pending·0 cites
- 1557US2024033277A1Methods for treating autoimmune diseasesNEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL·Filed 2021·Application pending·0 cites
- 1653US2015050296A1Methods and compositions for inhibition of innate immune responses and autoimmunityDYNAVAX TECH CORP·Filed 2014·Application pending·0 cites
- 1750US2006193869A1Methods and compositions for induction or promotion of immune toleranceBARRAT FRANCK·Filed 2005·Application pending·0 cites
- 1848US2009131512A1Inhibition of type I in IFN productionINST NAT SANTE RECH MED·Filed 2008·Application pending·0 cites
- 1947US9476053B2Methods and compositions for inhibition of immune responses and autoimmunityDYNAVAX TECH CORP·Filed 2015·Granted Oct 25, 2016·0 cites·37 claims
- 2047US2016003807A1Tlr8 transgenic animalsDYNAVAX TECH CORP·Filed 2015·Application pending·0 cites
- 2144US2011123561A1Methods and compositions for induction or promotion of immune toleranceDYNAVAX TECH CORP·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →